Navigation Links
Fincor (FINC) Makes a Share Transfer and Enters the Market With ACTRx a New Malaria and Dengue Fever Treatment
Date:5/1/2009

NEW YORK and NASSAU, The Bahamas, May 1 /PRNewswire-FirstCall/ -- Fincor (Pink Sheets: FINC) through a share split with Prospero Group (Pink Sheets: PRPG), a leading company in the field of water technologies, enlarges its portfolio with the new ACTRx Malaria and Dengue fever treatment. Fincor also acquired the WETTECH and Advanced Cavitation Technologies.

Fincor, acquired a majority of ACTRx International Inc., which combines several natural drugs to fight Malaria and Dengue fever and looks to become a premier global supplier of Malaria and Dengue cures, preventatives, maintenance and information products and services.

According to the World Health Organization, over 3 billion people live in areas at risk of malaria transmission, and annually over one million deaths are attributable to it -- 90% of which are to children under the age of five. However, malaria is a preventable and treatable disease, and the United Nations has called for elimination of all malaria deaths by the end of 2015, a goal which President Obama committed the United States to supporting on April 24th, 2009. The pharmaceutical package available through ACTRx will be a strong leader in the global fight against these unnecessary deaths from malaria. Additionally, it will assist in protecting and treating the 2.5 billion people at risk from dengue fever, and the 5 million dengue infections that occur each year. Prospero Group's intention is to research, review and objectively resolve the issues that keep these diseases active in our global society.

Fincor also acquired WETTECH marketed as Prospero Water Technologies and the Advanced Cavitation Technology.

About Fincor Inc.: Fincor Inc. is a technology and pharmaceutical company. It has recently acquired ACTRx International Inc. which produces Malaria and Dengue fever drugs in order to become the premier global supplier of Malaria and Deng
'/>"/>

SOURCE Fincor Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Web Portal Makes Organ Donation Easy
2. Advanced Cell Technologys Dr. Robert Lanza Makes List of 100 Most Inspiring People in the Life-Sciences Industry
3. NanoLogix Inc. Appoints Director of IP and Makes Progress on Rapid Anthrax Detection
4. Argonne researcher studies what makes quantum dots blink
5. Modifying an anti-cancer drug makes it more specific
6. NanoLogix, Inc. Makes Stock Pick List
7. Pharsight Makes Strong Contribution to Inaugural American Conference on Pharmacometrics
8. CSCs Dr. Robert M. Wah Makes Top 10 in 50 Most Powerful Physician Executives List
9. AMT Makes Important Advance in the Development of its Gene Therapy for Hemophilia B -Company Accesses Technology to Prevent Immune Response
10. University of Pennsylvania engineers reveal what makes diamonds slippery at the nanoscale
11. Roche Makes Offer to Acquire All Outstanding Shares of Genentech for US$89.00 Per Share in Cash
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... 18, 2014 Scientists at NYU Langone Medical Center ... efficiency of the process for turning adult cells into ... including vitamin C. Using the new technique in mice, ... from adult skin cells by more than 20-fold compared ... efficient and reliable, and thus should generally accelerate research ...
(Date:9/19/2014)... , Sept. 19, 2014  An entire month ... of inherited neuropathies – Charcot-Marie-Tooth disease (CMT) – a ... legs, causing extreme muscle atrophy, weakness, and foot and ... US and millions worldwide. CMT is a progressive disease, ... their legs, requiring mobility devices such as leg braces, ...
(Date:9/19/2014)... Sept. 19, 2014 Pfenex Inc. (NYSE MKT: ... of high-value and difficult to manufacture proteins including biosimilar ... the 21 st Annual NewsMakers in the Biotech ... Bertrand Liang , chief executive officer of Pfenex, ... and business strategy on Friday, September 26, 2014 at ...
(Date:9/19/2014)... Minnesota (PRWEB) September 19, 2014 ... related food industries will gather October 5–8, 2014, ... the Rhode Island Convention Center in Providence, Rhode ... feature the work of food scientists, chemists, microbiologists, ... control, and food production management. To date, 1,000 ...
Breaking Biology Technology:NYU Langone scientists report reliable and highly efficient method for making stem cells 2NYU Langone scientists report reliable and highly efficient method for making stem cells 3September is Charcot-Marie-Tooth (CMT) Awareness Month - Scheduled events, activities and important partnerships announced throughout the month! 2Pfenex to Present at Upcoming Industry Conference on September 26 2Latest Research on Cereal Grain Quality, Health Benefits and Food Production to be Presented During the AACC International Annual Meeting 2Latest Research on Cereal Grain Quality, Health Benefits and Food Production to be Presented During the AACC International Annual Meeting 3
... 2 or 3 patients achieve undetectable HCV RNA levels, following 4 weeks of treatment with ... ... with Pegasys ... plus Copegus -, PRINCETON, N.J., Sept. 8 Pharmasset, Inc.,(Nasdaq: VRUS ) announces ...
... Whalen as Solutions Director. , ... ... [Symphony Management Consulting] announced that it has appointed A.J. Whalen ... from Wellesley Information Services (WIS) where he was responsible for ...
... helps visitors to electronica 2008 in Munich and covers topics such ... sources of pre-show information useful in planning a trip, online registration ... an extensive list of web links to travel, hotel, city and ... ...
Cached Biology Technology:Pharmasset Reports Preliminary Results of a 4-week Proof-of-Concept Combination Study of R7128 for the Treatment of Chronic Hepatitis C in Genotype 2 or 3 Non-Responders 2Pharmasset Reports Preliminary Results of a 4-week Proof-of-Concept Combination Study of R7128 for the Treatment of Chronic Hepatitis C in Genotype 2 or 3 Non-Responders 3Pharmasset Reports Preliminary Results of a 4-week Proof-of-Concept Combination Study of R7128 for the Treatment of Chronic Hepatitis C in Genotype 2 or 3 Non-Responders 4Pharmasset Reports Preliminary Results of a 4-week Proof-of-Concept Combination Study of R7128 for the Treatment of Chronic Hepatitis C in Genotype 2 or 3 Non-Responders 5Pharmasset Reports Preliminary Results of a 4-week Proof-of-Concept Combination Study of R7128 for the Treatment of Chronic Hepatitis C in Genotype 2 or 3 Non-Responders 6Symphony Managemnt Consulting Hires New Solutions Director 2Free White Paper Now Available: How to get the most from your visit to electronica 2008 in Munich 2Free White Paper Now Available: How to get the most from your visit to electronica 2008 in Munich 3
(Date:9/18/2014)... deep in the primitive brainstem has revealed how we ... School of Medicine and the University at Buffalo School ... second "sleep node" identified in the mammalian brain whose ... produce deep sleep. , Published online in August in ... half of all of the brain,s sleep-promoting activity originates ...
(Date:9/18/2014)... system that can operate inside the bore of an ... a biomedical research partnership program at Brigham and Women,s ... the robot, in conjunction with real-time MRI images, can ... and less discomforting for the patient. The novel system ... with greater precision. , Developed by a team of ...
(Date:9/18/2014)... No matter how many times it,s demonstrated, ... communicating creatures. , But by using a ... radically alter their behavior to suit their population. ... them are present, and act accordingly. , Once ... it may change from innocuous to pathogenic, or ...
Breaking Biology News(10 mins):No sedative necessary: Scientists discover new 'sleep node' in the brain 2Trial begins for MRI-compatible robot designed to improve accuracy of prostate biopsies 2Trial begins for MRI-compatible robot designed to improve accuracy of prostate biopsies 3Trial begins for MRI-compatible robot designed to improve accuracy of prostate biopsies 4Trial begins for MRI-compatible robot designed to improve accuracy of prostate biopsies 5Researchers study vital 'on/off switches' that control when bacteria turn deadly 2Researchers study vital 'on/off switches' that control when bacteria turn deadly 3
... 2012 /PRNewswire-iReach/ -- Global Information Inc. is excited ... for Boston, MA in the Spring of 2012. ... April 30 – May 4, 2012 : Cambridge Healthtech Institute ... in Boston, MA. This comprehensive event encompasses 12 tracks, ...
... 14, 2012) A research team has identified epigenetic ... gene expression, within reprogrammed skin cells. These signatures can ... skin cells or induced pluripotent stem cells (iPSCs), cells ... the expression of the protein is controlled brings us ...
... Gutenberg University Mainz (JGU) in Germany have developed a ... the dynamics of proteins is necessary in order to ... molecular level. To date, this information has been obtained ... unfortunately this changes the proteins under investigation and thus ...
Cached Biology News:Annual Drug Discovery Conferences Being Held in Boston MA, Spring 2012 2Annual Drug Discovery Conferences Being Held in Boston MA, Spring 2012 3Epigenetic signatures direct the repair potential of reprogrammed cells 2Gold nanoantennas detect proteins 2
... is the most advanced thermal cycler ever ... performance, the Dyad also boasts graphical programming ... navigation via touch pad or mouse. ... economically expanded to a four-bay system with ...
Caliper offers a wide array of standard LabChip products designed to be used in combination with our AMS 90 and LabChip 3000 microfluidic platforms....
... that made the original Gene Pulser apparatus and ... has been applied in the Gene Pulser II ... design of the Gene Pulser II system has ... has the widest range of settings to target ...
... Experion Pro260 reagents and supplies, for ... supplies sufficient to perform protein analysis ... automated electrophoresis system. Supplied are 3 ... microliters Pro260 stain, 60 microliters Pro260 ...
Biology Products: